{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":529,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":529,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"c3f9da90b87c","filters":{"venue":"Molecular Therapy"}},"results":[{"id":"W2143743183","doi":"10.1038/mt.2010.85","title":"Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms","year":2010,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1215,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Encana (Canada)","funders":"Alnylam Pharmaceuticals","keywords":"Asialoglycoprotein receptor; Apolipoprotein E; LDL receptor; In vivo; Endogeny; Receptor; In vitro; Small interfering RNA; Cell biology; Ligand (biochemistry); Chemistry; RNA interference; Biology; Lipoprotein; Biochemistry; Transfection; Hepatocyte; Cholesterol; RNA; Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01282517653924593,"gpt":0.2131286059002929,"spread":0.200303429361047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001048996,0.0002168466,0.0001877627,0.00005814617,0.00006551141,0.00002207976,0.0002149729,0.0001777655,0.00001750892],"category_scores_gemma":[0.000004151465,0.0001755825,0.0000858899,0.00007934263,0.0001258312,0.000003565789,0.00003171577,0.00013039,0.000003196687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000345635,"about_ca_system_score_gemma":0.0001053995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004361048,"about_ca_topic_score_gemma":0.00003261739,"domain_scores_codex":[0.9990605,0.00004345607,0.0001720115,0.0003240144,0.0001600946,0.0002399144],"domain_scores_gemma":[0.9992263,0.000008493823,0.00009385448,0.0004433655,0.0001576015,0.00007041373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004005734,0.0001105068,0.0003136029,0.000007785397,0.0001663363,0.00002697133,0.00006772925,0.00003511977,0.9928255,0.00008374018,0.000007390724,0.005954713],"study_design_scores_gemma":[0.001140775,0.001614131,0.0002317561,0.000008523871,0.00002637911,0.00005534656,0.00003619349,0.00005807483,0.9952241,0.0001788805,0.001194942,0.000230892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890405,0.002193097,0.008176698,0.00006201652,0.0000890499,0.0002326544,0.00001720758,0.00001528648,0.0001734853],"genre_scores_gemma":[0.9950995,0.0005297997,0.002968775,0.001214801,0.00003599446,0.00002055713,0.00004984759,0.00004210656,0.00003856276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006059052,"threshold_uncertainty_score":0.7160047,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2600400434","doi":"10.1016/j.ymthe.2017.03.013","title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","year":2017,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Acuitas Therapeutics (Canada); University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Medical Research Council Canada; Canadian Institutes of Health Research; Genome British Columbia; Alnylam Pharmaceuticals","keywords":"Gene silencing; Genetic enhancement; RNA interference; Small interfering RNA; Computational biology; Genome editing; Gene; Gene delivery; Biology; Bioinformatics; Medicine; RNA; CRISPR; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.09359412117780753,"gpt":0.3576907772856159,"spread":0.2640966561078084,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002807049,0.0004549236,0.0008750238,0.00007375462,0.0001936704,0.0002035182,0.0007275004,0.0004242766,0.000007787216],"category_scores_gemma":[0.00003742209,0.000365144,0.000735549,0.00004468875,0.00006825346,0.000004735881,0.00008380933,0.0001139387,0.00003912121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001890705,"about_ca_system_score_gemma":0.0001772418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001651563,"about_ca_topic_score_gemma":0.000001447729,"domain_scores_codex":[0.9982846,0.0001379348,0.000414726,0.0006228717,0.0001380691,0.0004017729],"domain_scores_gemma":[0.9982871,0.00001677989,0.0003478902,0.001134026,0.0001319633,0.00008219346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000586432,0.00006337162,0.000001311801,0.001044709,0.0009274231,0.00001273165,0.00002663935,0.000009344291,0.09187062,0.00005221735,0.0008941037,0.9050389],"study_design_scores_gemma":[0.000373477,0.0003965398,1.753901e-7,0.0007134928,0.0001069852,0.00002811409,0.000009635624,0.000006579628,0.03282915,0.00001551997,0.9650909,0.0004294911],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002068695,0.9944537,0.001479377,0.00001725524,0.0006372591,0.001141097,0.00007535102,0.00002072113,0.0001065178],"genre_scores_gemma":[0.0007861778,0.9957529,0.0001185945,0.0001244143,0.0007337232,0.0006350829,0.0003742216,0.0001184741,0.001356372],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9641967,"threshold_uncertainty_score":0.9998801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111331330","doi":"10.1016/j.ymthe.2020.12.007","title":"Current Clinical Applications of In Vivo Gene Therapy with AAVs","year":2020,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":745,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Eye Institute; National Heart, Lung, and Blood Institute; Pfizer Canada; Canadian Institutes of Health Research; Novartis; Amicus Therapeutics; Sarepta Therapeutics; National Institutes of Health; Pfizer","keywords":"Genetic enhancement; Medicine; Choroideremia; Spinal muscular atrophy; Bioinformatics; Disease; Pathology; Biology; Genetics; Ophthalmology; Gene; Retinal","retraction":null,"screen_n_in":null,"score":{"opus":0.0671737211929952,"gpt":0.4214098242799977,"spread":0.3542361030870025,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005391619,0.0005844468,0.00149886,0.0001922054,0.00003967944,0.00002531826,0.0009670304,0.0004508509,0.00006079829],"category_scores_gemma":[0.00001770945,0.0004534099,0.0007277807,0.0006673392,0.0002267639,0.000002685363,0.000114921,0.0005847634,0.00002542462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003813605,"about_ca_system_score_gemma":0.0009559359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006049562,"about_ca_topic_score_gemma":0.00001882807,"domain_scores_codex":[0.9964152,0.0007593858,0.0009705188,0.001002625,0.0004212283,0.000431038],"domain_scores_gemma":[0.9979157,0.00003753804,0.0004265552,0.00128885,0.0001409181,0.0001904515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009570641,0.0004595894,0.00003698858,0.0004234615,0.0004868114,0.00001918422,0.00001626104,0.0000047162,0.01133346,0.00001376755,0.00009073913,0.986158],"study_design_scores_gemma":[0.001475283,0.003433202,0.000003297997,0.000402158,0.00004167904,0.00001195299,0.000002863735,0.000002337238,0.03147408,0.00002313333,0.962685,0.0004449417],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002686667,0.9927468,0.001787929,0.00004501876,0.00005894184,0.002449833,0.0001005521,0.00001811177,0.0001060936],"genre_scores_gemma":[0.0002650319,0.9974149,0.0003352447,0.0001875278,0.0002809679,0.000982894,0.0003032009,0.0001760197,0.00005417334],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.985713,"threshold_uncertainty_score":0.9997917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981575054","doi":"10.1038/mt.2011.189","title":"Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation","year":2011,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":710,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Bystander effect; Indoleamine 2,3-dioxygenase; Macrophage; Cytokine; Biology; Immunology; Cell biology; Tryptophan; Genetics; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.02649136202314328,"gpt":0.2375944766062781,"spread":0.2111031145831349,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005017098,0.00014763,0.000142086,0.00009874098,0.0000884,0.00001761372,0.0001033506,0.00007464086,0.000146556],"category_scores_gemma":[0.00001599318,0.0001090896,0.00003474408,0.0001690418,0.0001273247,0.0001074428,0.0000250267,0.0001126853,0.000002686701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008788412,"about_ca_system_score_gemma":0.000007815037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001755373,"about_ca_topic_score_gemma":0.000002719223,"domain_scores_codex":[0.9991165,0.0001022724,0.0001538809,0.0002809938,0.0001942402,0.0001521141],"domain_scores_gemma":[0.9995905,0.0000137669,0.0001138679,0.0002044857,0.00002700008,0.00005037409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001923731,0.000175445,0.0004449834,0.00001213079,0.00001180316,0.00001956709,0.0007452125,0.000003832369,0.9957438,0.0004917998,0.00001328142,0.002145797],"study_design_scores_gemma":[0.001814193,0.0003974487,0.02080657,0.00002560357,0.000003293154,0.00001290258,0.0000827906,0.00004396239,0.9760138,0.0006295198,0.00003933825,0.0001305729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997506,0.0002303656,0.0015808,0.00002056978,0.00005098618,0.0002441369,0.000006976553,0.00004393789,0.0003162127],"genre_scores_gemma":[0.9995279,0.00008514493,0.00009067309,0.0001445012,0.0000102633,0.0000110716,0.000007490002,0.00002599765,0.00009692536],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02036158,"threshold_uncertainty_score":0.4448544,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029397995","doi":"10.1038/mt.2013.124","title":"Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics","year":2013,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":619,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Encana (Canada)","funders":"Alnylam Pharmaceuticals","keywords":"Biocompatibility; Tolerability; RNA interference; Nanotechnology; Chemistry; Pharmacology; Medicine; Materials science; RNA; Biochemistry; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.0185276471292557,"gpt":0.2448197405972732,"spread":0.2262920934680175,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001793119,0.0002455236,0.0002631812,0.00008261809,0.00007731672,0.0000470844,0.0003449103,0.0001967146,0.00003675331],"category_scores_gemma":[0.00001474539,0.0002134274,0.0002323054,0.0001339862,0.0000839655,0.00001212365,0.00004283539,0.00006749976,0.00002452332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001395029,"about_ca_system_score_gemma":0.00007318825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008554842,"about_ca_topic_score_gemma":0.000002831238,"domain_scores_codex":[0.9986239,0.00008840537,0.0003784681,0.0003804242,0.0001544633,0.0003743529],"domain_scores_gemma":[0.9988506,0.00002268514,0.0001535953,0.0004945153,0.0004058839,0.00007269503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001987796,0.0001020193,0.0002079237,0.00003410024,0.0002293704,0.000001499244,0.00008300513,0.00006630509,0.9781452,0.00003467054,0.0005828864,0.02031419],"study_design_scores_gemma":[0.001060663,0.0009464632,0.0001165785,0.0000464536,0.00002853778,0.00001747872,0.0001884014,0.0003358283,0.9898371,0.0001032452,0.007058544,0.0002606723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849762,0.01035353,0.003590359,0.0002069415,0.0001613627,0.0006213132,0.00001211868,0.00002422321,0.00005389974],"genre_scores_gemma":[0.9945738,0.002781366,0.0008593758,0.001048888,0.0001199831,0.0001602155,0.00006836523,0.00004999733,0.0003379803],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02005352,"threshold_uncertainty_score":0.8703318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102875193","doi":"10.1038/mt.sj.6300145","title":"Stem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and Therapy","year":2007,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Stem Cell Network","funders":"","keywords":"Biology; MYF5; Stem cell; Cell biology; Progenitor cell; Myocyte; Immunology; Embryonic stem cell; Skeletal muscle; Cellular differentiation; Endothelial stem cell; Adult stem cell; Transplantation; Myogenesis; MyoD; Anatomy; Internal medicine; Genetics; Medicine; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.04302451499322955,"gpt":0.3149040793918386,"spread":0.271879564398609,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003139308,0.0004567125,0.001197292,0.0003083665,0.00003914989,0.00001744398,0.00007619268,0.0002592337,0.00001175312],"category_scores_gemma":[0.000004223847,0.0003008223,0.0001128679,0.0002750123,0.0001018361,0.00001792348,0.00002288142,0.0004101033,0.000007359797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000611752,"about_ca_system_score_gemma":0.0001356713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004255663,"about_ca_topic_score_gemma":7.393106e-7,"domain_scores_codex":[0.9984826,0.00007719264,0.0004253692,0.0004466395,0.0002178577,0.000350373],"domain_scores_gemma":[0.9994231,0.00003664114,0.00009644277,0.0002390616,0.00003654232,0.0001682076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009882667,0.00006292707,0.00001049346,0.001474089,0.0001715021,0.0003789493,0.0002073199,2.016269e-7,0.001313961,0.00002414938,0.0000355241,0.996311],"study_design_scores_gemma":[0.001644198,0.0002252342,0.00009083848,0.003840436,0.00004150321,0.0001594269,0.00002210733,0.000002945317,0.00141946,0.000001166984,0.9922537,0.0002990383],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01214898,0.985671,0.0005807796,0.00002833029,0.0002011499,0.001266538,0.000003432743,0.00004712727,0.00005265474],"genre_scores_gemma":[0.0002958264,0.9956695,0.001384499,0.00006652765,0.0001678639,0.0001016567,0.00002915049,0.00009924612,0.002185746],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.996012,"threshold_uncertainty_score":0.9999444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1538766821","doi":"10.1038/mt.2015.103","title":"Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":515,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"","keywords":"Messenger RNA; Biology; Nucleoside; Erythropoietin; Computational biology; Cell biology; Biochemistry; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03129525300198464,"gpt":0.2921426753457754,"spread":0.2608474223437908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003049993,0.000262261,0.0002269826,0.00008352864,0.00004093957,0.00004924029,0.0003533612,0.0002138332,0.00001465702],"category_scores_gemma":[0.00004767163,0.0002400319,0.0001001776,0.0001632687,0.000064739,0.00001410289,0.00004221048,0.00015163,0.00002235004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004028128,"about_ca_system_score_gemma":0.00009588766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000850967,"about_ca_topic_score_gemma":0.00002182286,"domain_scores_codex":[0.9984998,0.0001889854,0.0002355951,0.0005110614,0.0001873689,0.0003772643],"domain_scores_gemma":[0.9990472,0.000005353946,0.00006821757,0.0005524025,0.0001669076,0.0001599549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004160341,0.000234139,0.0008816816,0.000003023631,0.00006307218,0.00001554249,0.0003038559,0.0001319168,0.993036,0.0001336364,0.00006726858,0.004713853],"study_design_scores_gemma":[0.002045001,0.0009950551,0.001295301,0.00001919717,0.000003620077,0.00001024353,0.0001493571,0.0004570856,0.9915329,0.0005131916,0.00266112,0.000317971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940214,0.002083574,0.002452704,0.0001356496,0.0000426444,0.0008734654,0.00002286267,0.00003598681,0.0003317735],"genre_scores_gemma":[0.9977047,0.0002470235,0.0008842056,0.0004194813,0.00009295555,0.0003785563,0.000133001,0.00005135801,0.00008873337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004395882,"threshold_uncertainty_score":0.9788216,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035342267","doi":"10.1016/j.ymthe.2006.05.016","title":"Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation","year":2006,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":495,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; American Heart Association","keywords":"Protein kinase B; Mesenchymal stem cell; Cre recombinase; Paracrine signalling; Cell biology; Cardiac function curve; Stem cell; Cancer research; Bone marrow; Biology; Medicine; Immunology; Signal transduction; Internal medicine; Transgene; Heart failure; Genetically modified mouse; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01279741112760101,"gpt":0.2438652336667378,"spread":0.2310678225391368,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005503271,0.000377631,0.0005609372,0.0002252937,0.0002001867,0.00015319,0.0001082059,0.0002885482,0.0002238082],"category_scores_gemma":[0.00003131061,0.0002897266,0.000300097,0.0003533446,0.0001128624,0.0001502973,0.0001075972,0.0003752752,0.00003240455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001867699,"about_ca_system_score_gemma":0.0001426268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001864667,"about_ca_topic_score_gemma":0.000002633674,"domain_scores_codex":[0.9966972,0.0004114874,0.0005834016,0.0006535407,0.001077814,0.0005765019],"domain_scores_gemma":[0.9985059,0.0001107859,0.0001724599,0.0006741738,0.0002776521,0.0002589815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001008782,0.0001772723,0.003289112,0.0001792861,0.0002083416,0.000103306,0.0001115717,0.00002428907,0.9787834,0.0001904369,0.0001979806,0.01572624],"study_design_scores_gemma":[0.00306653,0.001206164,0.02188681,0.0001786515,0.0001555397,0.00001323074,0.00007344779,0.003768236,0.9633366,0.0002787629,0.00564675,0.0003892715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787301,0.00233503,0.01533675,0.0001822814,0.0003071022,0.001591291,0.00001014578,0.0002179967,0.001289289],"genre_scores_gemma":[0.995889,0.000237268,0.001256477,0.0002646076,0.0002341888,0.0000885773,0.00008523319,0.00008486213,0.001859757],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0185977,"threshold_uncertainty_score":0.9999555,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002868143","doi":"10.1038/sj.mt.6300374","title":"Targeted Migration of Mesenchymal Stem Cells Modified With CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance","year":2008,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":443,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Division of Chemistry","keywords":"Mesenchymal stem cell; CXCR4; Homing (biology); Myocardial infarction; Medicine; Cardiac function curve; Cell therapy; Cardiology; CXC chemokine receptors; Chemokine; Progenitor cell; Stem cell; Chemokine receptor; Internal medicine; Heart failure; Pathology; Receptor; Biology; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02119652597252542,"gpt":0.2447175984740113,"spread":0.2235210725014859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002917054,0.0002766484,0.0005629132,0.0002426059,0.00009975652,0.00001403946,0.0001895449,0.0001346589,0.00004570215],"category_scores_gemma":[0.00001076588,0.000211617,0.0001687048,0.0006854385,0.000119762,0.0000779697,0.00004462202,0.00023395,0.0000405567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008185844,"about_ca_system_score_gemma":0.0002632185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002069853,"about_ca_topic_score_gemma":0.000002356005,"domain_scores_codex":[0.99754,0.0001560242,0.000368559,0.000437392,0.001019852,0.0004781942],"domain_scores_gemma":[0.9984238,0.0000336611,0.0001029765,0.0006912795,0.0004525734,0.0002957021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001410453,0.0001146049,0.004110491,0.00006168589,0.000272255,0.0000906045,0.0007154777,0.0004217585,0.986867,0.000009353455,0.0002154581,0.005710856],"study_design_scores_gemma":[0.001704531,0.001959664,0.02891449,0.00004069431,0.00002739054,0.00003003192,0.00005308915,0.001126897,0.9631537,0.000001560069,0.002767875,0.0002200978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942341,0.001176688,0.001609912,0.0003244368,0.00008679514,0.001532347,0.00001165346,0.0000621923,0.000961897],"genre_scores_gemma":[0.9955162,0.0007738298,0.00180759,0.0003429492,0.00006979342,0.0001077642,0.00003492906,0.00006257203,0.001284349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.024804,"threshold_uncertainty_score":0.862949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016394521","doi":"10.1016/j.ymthe.2020.04.018","title":"A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"National Institute of Allergy and Infectious Diseases; U.S. Public Health Service; National Institutes of Health; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Virology; Nucleoprotein; Neuraminidase; Virus; Hemagglutinin (influenza); Biology; Influenza A virus; Antigen; Antigenic drift; Immunization; Influenza vaccine; Immune system; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.08804763292262706,"gpt":0.3596738884916267,"spread":0.2716262555689996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000342206,0.0003187242,0.0004826242,0.0002011998,0.0001170311,0.00004769511,0.0001965128,0.0001480814,0.00006388493],"category_scores_gemma":[0.0007310992,0.0002746512,0.000155853,0.0005379437,0.00005977712,0.0001317082,0.00009688575,0.0006018434,0.000143042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001366152,"about_ca_system_score_gemma":0.0001136674,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009217075,"about_ca_topic_score_gemma":0.00003741128,"domain_scores_codex":[0.9977065,0.0002049603,0.000488806,0.0005540968,0.0005004694,0.0005451838],"domain_scores_gemma":[0.9991363,0.00003061748,0.0001220771,0.0002851903,0.0002099236,0.0002158933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002939373,0.0002876279,0.002263935,0.0001302438,0.0001782554,0.0002275142,0.002065142,0.0002333865,0.9783049,0.00001417155,0.0002595104,0.01309597],"study_design_scores_gemma":[0.01747198,0.00164321,0.02203787,0.0001771918,0.0000347968,0.00001384621,0.0002174405,0.009063624,0.88838,0.00007603446,0.06034352,0.0005404862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844022,0.007477543,0.001513026,0.003417257,0.00004303102,0.002687437,0.000007055309,0.0002129992,0.0002394621],"genre_scores_gemma":[0.9812262,0.000615801,0.002886181,0.01455154,0.0001312132,0.0004285872,0.000008093484,0.00009103469,0.00006134294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08992486,"threshold_uncertainty_score":0.9999706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108883303","doi":"10.1038/mt.2011.276","title":"The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers","year":2011,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":308,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Terry Fox Foundation","keywords":"Oncolytic virus; Vaccinia; Biology; Virology; Cancer research; Cancer; Gene; Virus; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02357912093871324,"gpt":0.2766259929282771,"spread":0.2530468719895638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002876326,0.0002808264,0.000235074,0.00008636753,0.0001198091,0.00004010415,0.0004537604,0.0001849883,0.00002088053],"category_scores_gemma":[0.00001678466,0.0002356015,0.00006678996,0.0003230479,0.0002223673,0.000006278196,0.00008217124,0.000279573,0.00000399701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001745963,"about_ca_system_score_gemma":0.0003328386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002173798,"about_ca_topic_score_gemma":0.003965739,"domain_scores_codex":[0.9979736,0.0003579225,0.0002852198,0.0005986911,0.0002024971,0.0005821205],"domain_scores_gemma":[0.9991303,0.00003182414,0.00009925603,0.0005488865,0.00007120126,0.0001184943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002042337,0.0001010961,0.006052459,0.00000446019,0.00009337724,0.00002298048,0.0003572446,0.0001630154,0.9707067,0.000004780761,0.0001437936,0.02030774],"study_design_scores_gemma":[0.0017075,0.001511048,0.00858574,0.00001703794,0.000004275607,0.00000437903,0.0000901156,0.0001798731,0.9860824,0.0001552475,0.001382399,0.0002799605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876504,0.01116033,0.00006834264,0.0001390259,0.00003893347,0.0007026383,0.00002687315,0.00001489636,0.0001985523],"genre_scores_gemma":[0.9890153,0.009817254,0.000123656,0.0005114566,0.00002472364,0.0003551944,0.00001618228,0.00006854141,0.00006765876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02002778,"threshold_uncertainty_score":0.9607552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3087575682","doi":"10.1016/j.ymthe.2020.09.024","title":"A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":293,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Apoptosis; Reactive oxygen species; Lipid peroxidation; Cell biology; Programmed cell death; Biology; Chemistry; Biochemistry; Oxidative stress","retraction":null,"screen_n_in":null,"score":{"opus":0.02056453374518945,"gpt":0.2709041963008748,"spread":0.2503396625556853,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002442593,0.0003994846,0.0003467193,0.0001603288,0.0001167299,0.0001415849,0.0006256765,0.0003736562,0.0001705631],"category_scores_gemma":[0.00006657344,0.0004190814,0.0002569277,0.0004704376,0.00004982839,0.00001288933,0.0003040928,0.0004416496,0.0001033278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008077054,"about_ca_system_score_gemma":0.0001096204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008200695,"about_ca_topic_score_gemma":0.00002584273,"domain_scores_codex":[0.9973294,0.0001891265,0.0003859855,0.0009237021,0.000477695,0.0006941591],"domain_scores_gemma":[0.9989159,0.000009248578,0.0001011551,0.0005690618,0.0001166999,0.0002879916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005868383,0.0001143455,0.00005299295,0.00002696665,0.0001625774,0.00009428457,0.0002295859,0.001191005,0.990769,0.00005679527,0.0001923859,0.006523281],"study_design_scores_gemma":[0.002148692,0.0006227261,0.0001022227,0.00003761372,0.00001508208,0.00001018854,0.0001305851,0.001994523,0.9913295,0.00003261637,0.003099287,0.0004769674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9635704,0.001425867,0.03179412,0.001623805,0.000117211,0.0007445135,0.00001113076,0.00005077832,0.0006622396],"genre_scores_gemma":[0.9937566,0.00166054,0.000755163,0.003224466,0.0001753432,0.0001050859,0.00007830645,0.0001615734,0.00008290478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03103896,"threshold_uncertainty_score":0.9998261,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970986383","doi":"10.1038/mt.2011.201","title":"Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin","year":2011,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":292,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; Killam Trusts","keywords":"Huntingtin; Gene silencing; Biology; Genetics; Mutant; Allele; Huntington's disease; Oligonucleotide; Single-nucleotide polymorphism; Gene; Huntingtin Protein; Molecular biology; Genotype; Disease; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03467090058476555,"gpt":0.2280903773916864,"spread":0.1934194768069208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003686233,0.0003541104,0.0003123347,0.0001977906,0.0002066742,0.00007695621,0.0004411068,0.00004722569,0.00002807144],"category_scores_gemma":[0.0003050451,0.0002898539,0.000146536,0.0005245659,0.0003065227,0.0001201094,0.0001063807,0.0002038661,0.000006744154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002821832,"about_ca_system_score_gemma":0.0000473115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007473575,"about_ca_topic_score_gemma":0.000003654177,"domain_scores_codex":[0.9969102,0.0007641029,0.0005022028,0.0007993745,0.0004864935,0.0005376785],"domain_scores_gemma":[0.9988345,0.0001679722,0.0002830833,0.0004839518,0.00008648187,0.000144028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002084254,0.0004078356,0.004077997,0.00001015624,0.00001077732,0.0001905248,0.002597006,0.0001102357,0.9897534,0.0002505305,0.00001090346,0.002372174],"study_design_scores_gemma":[0.0006466989,0.0002039604,0.04418784,0.00003204022,0.00001503683,0.00001030423,0.0002758838,0.0001634536,0.9536498,0.0004701375,0.00005599598,0.0002888486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997041,0.001286687,0.0003911621,0.0001549186,0.00009820425,0.0006709736,0.00001884788,0.00005193604,0.0002862098],"genre_scores_gemma":[0.9972671,0.00054034,0.0009036488,0.001128059,0.00004874666,0.00003163545,0.000003896196,0.0000709332,0.000005698002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04010985,"threshold_uncertainty_score":0.9999554,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2624872288","doi":"10.1016/j.ymthe.2017.05.022","title":"The Circular RNA Interacts with STAT3, Increasing Its Nuclear Translocation and Wound Repair by Modulating Dnmt3a and miR-17 Function","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":287,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Higher Education Commision, Pakistan; China Scholarship Council","keywords":"Chromosomal translocation; Cell biology; Function (biology); RNA; Biology; Rna processing; Chemistry; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.008709906529921162,"gpt":0.2401670790711231,"spread":0.231457172541202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002961039,0.0002087633,0.0001379294,0.00002299301,0.000791234,0.0003330859,0.0001929467,0.0001047959,0.000003990107],"category_scores_gemma":[0.00009505877,0.0001674286,0.00006892642,0.00003087396,0.0002072263,0.00002725303,0.00006187049,0.0001089919,0.000001163218],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001593595,"about_ca_system_score_gemma":0.0000308474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000621438,"about_ca_topic_score_gemma":0.00001698765,"domain_scores_codex":[0.9988291,0.0001364973,0.0001733777,0.0004435561,0.0001837176,0.0002337698],"domain_scores_gemma":[0.998953,0.0000186038,0.0001638676,0.0006717249,0.00008866822,0.0001040828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004672264,0.00003872973,0.001067935,0.00001578809,0.0002209744,0.000008725047,0.00009398109,0.00002454664,0.9768284,0.0001023584,0.00009091451,0.02104042],"study_design_scores_gemma":[0.007887951,0.001871262,0.08388609,0.000307534,0.0002668249,0.0003263371,0.0006903064,0.004265703,0.7844324,0.0008516932,0.113487,0.001726893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828432,0.01397371,0.002245269,0.0002551931,0.00005480354,0.0003382777,0.0000086574,0.00003128518,0.0002495563],"genre_scores_gemma":[0.997548,0.001545377,0.0002653381,0.0004077146,0.00005432162,0.00002130037,0.00004570657,0.00005712417,0.00005507432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.192396,"threshold_uncertainty_score":0.6827539,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987741335","doi":"10.1038/sj.mt.6300403","title":"A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas","year":2008,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":280,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre; Oncolytics Biotech (Canada); University of Calgary","funders":"","keywords":"Medicine; Virology; Pathology; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.02584841546116342,"gpt":0.3050530859248438,"spread":0.2792046704636804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002283929,0.0001841827,0.000304077,0.0001141388,0.00002986479,0.000004624487,0.0002288424,0.0001297234,0.0000282942],"category_scores_gemma":[0.00003930868,0.0001493403,0.0001007848,0.0002240011,0.0002466124,0.000004111545,0.0000246938,0.000104676,0.00000116046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002246331,"about_ca_system_score_gemma":0.0002915958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001172128,"about_ca_topic_score_gemma":0.00003021064,"domain_scores_codex":[0.9983661,0.0002490792,0.0004274358,0.0003344103,0.0003764425,0.0002465754],"domain_scores_gemma":[0.9990892,0.000009702056,0.000212753,0.0004183739,0.0001981959,0.00007179665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.3413091,0.00279229,0.0007317847,0.000008234041,0.00006118767,0.00005125477,0.00004949341,0.000008077232,0.6498374,0.00002234939,0.00002074801,0.005108114],"study_design_scores_gemma":[0.07870579,0.07913239,0.001451977,0.00001565488,0.000005483763,0.000006317034,0.000006149858,0.000007098196,0.840122,0.00002190758,0.0003631455,0.000162129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981086,0.0005962843,0.0001876082,0.00004256899,0.00005124365,0.0008850343,0.00002647801,0.000005835876,0.00009634791],"genre_scores_gemma":[0.9991781,0.0002300276,0.0002322953,0.0000677659,0.00002270805,0.00006036645,0.0001626406,0.00002326428,0.000022796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2626033,"threshold_uncertainty_score":0.6089921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2734515449","doi":"10.1016/j.ymthe.2017.07.004","title":"Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":280,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Research and Development; Graduate Women – New South Wales; Northwest University; Department of Health and Social Care; NIH Clinical Center; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services; Government of Canada; Geoffrey Beene Cancer Research Center; National Institute for Health and Care Research; National Cancer Research Institute","keywords":"Chimeric antigen receptor; CD19; Lymphoma; Medicine; Antigen; Receptor; Immunology; B cell; Cell; Cancer research; Biology; T cell; Antibody; Internal medicine; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.02657168721673962,"gpt":0.3032861052003658,"spread":0.2767144179836261,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004459816,0.0004123437,0.0006724916,0.0002170534,0.0003661113,0.0001199203,0.0005951587,0.0002346456,0.003303402],"category_scores_gemma":[0.00003686666,0.0003431949,0.0004338739,0.0002186155,0.0002380022,0.000147556,0.0001118197,0.0002593802,0.0001510668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008287132,"about_ca_system_score_gemma":0.0001911645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001049977,"about_ca_topic_score_gemma":0.000003879043,"domain_scores_codex":[0.9971335,0.0002462933,0.0005291575,0.0006147669,0.00081201,0.0006642688],"domain_scores_gemma":[0.996892,0.00005344045,0.0003850145,0.002100952,0.0002626045,0.0003059627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001682501,0.00301592,0.01856106,0.00005066703,0.000155317,0.0001377109,0.0006138217,8.533669e-7,0.9609182,0.000008482669,0.000364437,0.01449106],"study_design_scores_gemma":[0.01835688,0.0006894323,0.09450651,0.00007687023,0.00002062369,0.00001489866,0.00004722856,0.0001472384,0.8258918,0.00003034974,0.05988183,0.0003363382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896389,0.004138137,0.001048121,0.000782164,0.0002253293,0.001269292,0.00005892547,0.00007234402,0.002766743],"genre_scores_gemma":[0.9841714,0.009282957,0.0006619592,0.0007997698,0.0001667544,0.00007353735,0.0001231404,0.0001459613,0.004574526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1350264,"threshold_uncertainty_score":0.999902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051239163","doi":"10.1016/j.ymthe.2004.08.013","title":"Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer","year":2004,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":278,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa; Ottawa Regional Cancer Foundation","funders":"","keywords":"Ovarian cancer; Serous fluid; Histology; Cancer research; Medicine; Clear cell; Cancer; Stage (stratigraphy); Pathology; Cell; Ovary; Cell growth; Cell culture; Internal medicine; Biology; Oncology; Immunohistochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02132535203155667,"gpt":0.3084819971141273,"spread":0.2871566450825706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004246792,0.00008994318,0.0001337507,0.00003941579,0.00002818217,0.000007547569,0.0000688202,0.00003783979,0.00001406216],"category_scores_gemma":[0.000001863489,0.00008125359,0.00005062157,0.00006594354,0.00007384998,0.000004893142,0.00002249568,0.00002937535,1.644182e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008381873,"about_ca_system_score_gemma":0.00005797467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005802999,"about_ca_topic_score_gemma":0.00008339925,"domain_scores_codex":[0.9994453,0.00002991298,0.0001386102,0.0001606126,0.0001080531,0.0001175279],"domain_scores_gemma":[0.9996551,0.000001041682,0.00006621429,0.0001746115,0.00005801381,0.00004497558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008923079,0.0001084689,0.0004568749,0.00002074529,0.0001808891,0.000004775881,0.00009735155,0.00006050218,0.9935034,0.0004091168,6.624484e-7,0.005067998],"study_design_scores_gemma":[0.001570477,0.0004426203,0.002108699,0.00001566658,0.00001252021,0.000002820952,0.000008014421,0.00001055914,0.9947762,0.0007330778,0.000247822,0.00007152508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943194,0.001658704,0.003597128,0.00007619904,0.00001404293,0.0002353498,0.00004435084,0.000003178596,0.00005159416],"genre_scores_gemma":[0.9972585,0.002114186,0.0003246437,0.00007687716,0.00001439775,0.00004776469,0.0001286052,0.00001448736,0.00002052853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004996473,"threshold_uncertainty_score":0.3313425,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057672138","doi":"10.1038/sj.mt.6300215","title":"Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow","year":2007,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":277,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Inflammation; Virus; Medicine; Immunology; Virology; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.01298807240059896,"gpt":0.273092995067845,"spread":0.2601049226672461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006704316,0.0004141627,0.0002985689,0.0001839413,0.0002295412,0.00008103802,0.0005150941,0.0002174586,0.0002195505],"category_scores_gemma":[0.0000408556,0.0004006971,0.0002448723,0.0003260471,0.0001293668,0.00001283081,0.00008053249,0.0002558549,0.00006511847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004413919,"about_ca_system_score_gemma":0.0001668895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000311179,"about_ca_topic_score_gemma":0.00008578914,"domain_scores_codex":[0.9973996,0.0002201355,0.0004489116,0.0006553033,0.00052681,0.0007492923],"domain_scores_gemma":[0.9985641,0.00002343619,0.0001556242,0.0008311465,0.0002051042,0.0002205586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007646279,0.0002379458,0.0002616205,0.00001244772,0.0003384189,0.0001361488,0.0001060696,0.0004453125,0.9759968,0.000008505172,0.00006193454,0.01474854],"study_design_scores_gemma":[0.00527159,0.00253737,0.002867017,0.00001416265,0.00001113884,0.00004674848,0.00002615505,0.0001066823,0.9828132,0.00008000607,0.005748023,0.0004779374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911443,0.005784014,0.001357872,0.0001271471,0.0001243335,0.0008826672,0.00001844655,0.00008681561,0.0004743816],"genre_scores_gemma":[0.9957989,0.00146216,0.0009083268,0.0007570494,0.0003880473,0.0000788512,0.0001647542,0.0001321586,0.0003096819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0142706,"threshold_uncertainty_score":0.9998445,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2004817863","doi":"10.1016/j.ymthe.2005.05.006","title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice","year":2005,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":276,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Huntingtin; Transgene; Molecular biology; Biology; Huntingtin Protein; Huntington's disease; Small hairpin RNA; Genetically modified mouse; Polyglutamine tract; Messenger RNA; Cell biology; RNA; Mutant; Gene; Genetics; Internal medicine; Medicine; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.01806108146999728,"gpt":0.2701280630177234,"spread":0.2520669815477261,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002071117,0.0003216677,0.000383048,0.0002381597,0.00006747492,0.00003454699,0.0004845752,0.00006986278,0.0000803798],"category_scores_gemma":[0.0004808273,0.0003079596,0.0002350913,0.000573427,0.0002983344,0.000210782,0.00007481903,0.000194123,0.00001102136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002664308,"about_ca_system_score_gemma":0.000283913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001909472,"about_ca_topic_score_gemma":0.000004378213,"domain_scores_codex":[0.9969424,0.0005961682,0.0006350513,0.000698803,0.0006750948,0.000452479],"domain_scores_gemma":[0.998677,0.0001456299,0.0003341222,0.0004350644,0.00009705294,0.0003112002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001203286,0.0009529139,0.01558491,0.00004719589,0.00001452723,0.00002491806,0.0001965535,0.0009312875,0.9758204,0.000044588,0.00001493827,0.005164545],"study_design_scores_gemma":[0.002320775,0.0001477419,0.04933637,0.0001053828,0.00003566879,3.62115e-7,0.00001888118,0.000581436,0.9469965,0.0000289635,0.0001672582,0.0002606753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976728,0.0006511871,0.0001286477,0.0004491221,0.0001410702,0.0007411152,0.0001528566,0.00004665004,0.0000165822],"genre_scores_gemma":[0.9987653,0.0003051626,0.0002597133,0.0004402421,0.00008819817,0.0000483834,0.00003343525,0.00005159042,0.000007934897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03375146,"threshold_uncertainty_score":0.9999372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990622580","doi":"10.1016/j.ymthe.2005.09.014","title":"Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes","year":2005,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovative Targeting Solutions (Canada)","funders":"","keywords":"Liposome; Biodistribution; Immunogenicity; Nucleic acid; Transfection; Pharmacology; PEGylation; Genetic enhancement; In vivo; Drug delivery; Gene delivery; Chemistry; Polyethylene glycol; Biology; Immunology; Biochemistry; In vitro; Immune system; Biotechnology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.007020304168869783,"gpt":0.2624446377240292,"spread":0.2554243335551594,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001201788,0.0001534102,0.0001500484,0.00004842826,0.00004563289,0.00001808425,0.0000878321,0.00007244143,0.00000951904],"category_scores_gemma":[0.00004794619,0.0001454671,0.0000732642,0.00007490463,0.00006341298,0.000005299483,0.00005509645,0.00004809115,0.000009804876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005744153,"about_ca_system_score_gemma":0.00003210448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002454769,"about_ca_topic_score_gemma":0.000004022716,"domain_scores_codex":[0.9991236,0.0001055592,0.0001567148,0.0003115255,0.0001105719,0.0001920667],"domain_scores_gemma":[0.9994686,0.00001104301,0.00005137737,0.0002523749,0.00008720985,0.0001294585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007140536,0.00006944919,0.005888215,0.000005761513,0.00006202064,0.00001749771,0.00009739495,0.00004632948,0.9897435,0.000003267871,0.0004180411,0.002934518],"study_design_scores_gemma":[0.0005192729,0.0003522526,0.009537861,0.00001444932,0.00001111527,0.000002929245,0.0000253711,0.00005632066,0.9775852,0.000005858303,0.01169364,0.0001957512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939725,0.00426391,0.0008276835,0.0006243705,0.00002779954,0.0001596871,0.00007443857,0.00001128646,0.000038318],"genre_scores_gemma":[0.9972366,0.0009172367,0.0002089651,0.001156585,0.00005135949,0.000005728848,0.0001488246,0.00002211538,0.0002525623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01215828,"threshold_uncertainty_score":0.5931977,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3166016270","doi":"10.1016/j.ymthe.2021.06.004","title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":275,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Messenger RNA; Transfection; Biology; Spleen; T cell; Effector; Molecular biology; Cell biology; Immune system; Immunology; Cell culture; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.007956638733391112,"gpt":0.2174022923473841,"spread":0.209445653613993,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001188769,0.0002317812,0.0001777475,0.00006268454,0.0001150417,0.00007349405,0.000144425,0.0001651818,0.00002560513],"category_scores_gemma":[0.00002044873,0.0002462174,0.0001165788,0.0001278374,0.00003248648,0.000004352421,0.00008989652,0.0001109337,0.000008526742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000233943,"about_ca_system_score_gemma":0.00007510286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001789483,"about_ca_topic_score_gemma":0.000001428591,"domain_scores_codex":[0.998652,0.0001125815,0.0002570315,0.0005064724,0.0001586628,0.0003132717],"domain_scores_gemma":[0.999328,0.00001028992,0.00009263942,0.0003237007,0.0001574964,0.00008793399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003194321,0.00009340156,0.0001980227,0.00001982825,0.00003722715,0.00006442791,0.0001169152,0.005185275,0.9917823,0.000006585626,0.00009566702,0.002368424],"study_design_scores_gemma":[0.0009009113,0.0001762061,0.0003070903,0.0000192101,0.00001864375,0.00002694044,0.0001178605,0.004819467,0.9910492,0.00003362861,0.002230918,0.0002999191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694451,0.01379933,0.01600265,0.00007348681,0.000255142,0.000155517,0.000006085646,0.00001716585,0.0002455372],"genre_scores_gemma":[0.9933393,0.001158072,0.00464356,0.0003620393,0.00009948923,0.00001077855,0.00009366438,0.00004742018,0.0002456561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02389423,"threshold_uncertainty_score":0.999999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014855350","doi":"10.1038/mt.2009.70","title":"VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial","year":2009,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Victoria Heart Institute Foundation; Montreal Heart Institute; University of Ottawa; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Genetic enhancement; Revascularization; Placebo; Therapeutic angiogenesis; Cardiology; Clinical trial; Perfusion; Internal medicine; Ejection fraction; Angiogenesis; Surgery; Neovascularization; Pathology; Myocardial infarction; Heart failure; Gene; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.005967601918492373,"gpt":0.2420861311152361,"spread":0.2361185291967437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009867374,0.000159667,0.0002879782,0.00007177811,0.00002476895,0.000004986487,0.000151018,0.00004971549,0.00001637539],"category_scores_gemma":[0.00007376292,0.0001015471,0.0001983087,0.0002312017,0.00004177205,0.000038386,0.00002363918,0.0001021382,0.00000154995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000432124,"about_ca_system_score_gemma":0.00009367173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000221326,"about_ca_topic_score_gemma":0.000005975249,"domain_scores_codex":[0.9987799,0.00006234478,0.0003809236,0.0002459913,0.0003668402,0.0001639947],"domain_scores_gemma":[0.9989134,0.00002917789,0.0001896418,0.0005942924,0.0001882026,0.00008529751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.3061792,0.003817477,0.06213639,0.0000182049,0.0001085824,0.0000371708,0.0004877491,0.0003162424,0.3607057,0.000009318235,0.0001015483,0.2660824],"study_design_scores_gemma":[0.09310864,0.01003683,0.7774384,0.0002286239,0.00003035947,9.851155e-7,0.00003639853,0.00001475399,0.1180862,0.00002878457,0.0008457415,0.0001442552],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961876,0.001059376,0.00008519301,0.0006282845,0.0001039243,0.001749677,0.0000592648,0.00001077592,0.000115928],"genre_scores_gemma":[0.9989299,0.0001711276,0.000202701,0.0005026279,0.00002534815,0.0000325791,0.00005930438,0.00002011245,0.00005632656],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.715302,"threshold_uncertainty_score":0.4140971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095394300","doi":"10.1038/mt.2011.65","title":"Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide","year":2011,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":235,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Oncolytic virus; Immune system; Immunotherapy; Virus; Biology; Medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.06545864949714603,"gpt":0.3604463169356169,"spread":0.2949876674384709,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004502251,0.0007668272,0.001150992,0.0002163702,0.000170172,0.0001315015,0.0005238461,0.0006636055,0.00006898175],"category_scores_gemma":[0.0000191769,0.0006424989,0.0003785551,0.0002238865,0.0003205825,0.000006451545,0.0001945839,0.0003802776,0.00003102194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004134711,"about_ca_system_score_gemma":0.000361345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002160261,"about_ca_topic_score_gemma":0.00001968809,"domain_scores_codex":[0.9971614,0.0005110045,0.0005003859,0.00100348,0.0002497943,0.0005739016],"domain_scores_gemma":[0.9984019,0.00003612945,0.0002417172,0.001019424,0.00008455442,0.0002163126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009522404,0.0001058883,0.000006553881,0.0006262438,0.001120492,0.00003614889,0.00005771824,2.361296e-7,0.04079192,0.00009926796,0.000155708,0.9560476],"study_design_scores_gemma":[0.001050401,0.003388064,0.000003790672,0.0006170142,0.0000937067,0.0001030093,0.00001077101,7.175685e-7,0.02125489,0.0001267083,0.9726318,0.000719191],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01159577,0.9863289,0.0001186113,0.00002319352,0.00009167969,0.00120683,0.00002562977,0.00003392933,0.0005754594],"genre_scores_gemma":[0.0005443165,0.9971485,0.0001913775,0.0008286994,0.0001542156,0.0002753848,0.00006731772,0.0002617449,0.0005284159],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.972476,"threshold_uncertainty_score":0.9996026,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045343528","doi":"10.1038/sj.mt.6300341","title":"Generation of Potent and Stable Human CD4+ T Regulatory Cells by Activation-independent Expression of FOXP3","year":2007,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":231,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Vancouver Coastal Health Research Institute; University of British Columbia; Université de Montréal; Vancouver Coastal Health","funders":"","keywords":"FOXP3; Cell biology; Biology; Expression (computer science); Chemistry; Immunology; Immune system; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.01617372833256359,"gpt":0.241329393793307,"spread":0.2251556654607434,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002273258,0.00009458941,0.0001382238,0.0000845629,0.00007991231,0.000004808629,0.00005529335,0.000141895,0.00025901],"category_scores_gemma":[0.000004684526,0.00008605318,0.0000504159,0.00004844677,0.00005468889,0.00007463778,0.00001622801,0.0001018735,0.00000621803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002374491,"about_ca_system_score_gemma":0.00001055958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006511746,"about_ca_topic_score_gemma":0.000001369393,"domain_scores_codex":[0.9993249,0.00008491214,0.0002687191,0.000151215,0.00005263617,0.0001175999],"domain_scores_gemma":[0.9995227,0.00001713575,0.0001866229,0.0001788454,0.00008369011,0.00001098734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001638402,0.0001370102,0.00009393202,0.000006450503,0.00004442519,3.188767e-7,0.0001778062,0.00001499404,0.9927802,0.0001392252,0.002427908,0.004013909],"study_design_scores_gemma":[0.0009378557,0.0002074049,0.001021983,0.00001671062,0.000005797394,0.000002493431,0.0001140763,0.00000353698,0.9869098,0.00002229361,0.01068134,0.00007671342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841527,0.001726856,0.01304541,0.00002339353,0.0003973391,0.0001610609,0.000001987121,0.00001303966,0.0004782056],"genre_scores_gemma":[0.9975304,0.00008485845,0.00006258152,0.0001146962,0.000009896822,0.000003834023,0.0001050227,0.00001174892,0.002076942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01337771,"threshold_uncertainty_score":0.3509147,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2916541448","doi":"10.1016/j.ymthe.2019.02.013","title":"The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":225,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"University of Pennsylvania; Center for Outcomes Research and Evaluation, Yale School of Medicine","keywords":"Biology; Phenotype; Genetic enhancement; Transgene; Blood–brain barrier; Gene; Virology; Locus (genetics); Genetics; Central nervous system","retraction":null,"screen_n_in":null,"score":{"opus":0.009198197258394103,"gpt":0.2842873334632227,"spread":0.2750891362048286,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167002,0.0003805639,0.0002409482,0.00003008534,0.0004983798,0.000123521,0.00124398,0.0002563062,0.0001425361],"category_scores_gemma":[0.00004790324,0.0002314263,0.0003657712,0.0002328582,0.0004034904,0.000007510891,0.000103869,0.0003804784,0.0001147603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001644546,"about_ca_system_score_gemma":0.0001945993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002551901,"about_ca_topic_score_gemma":0.00009719842,"domain_scores_codex":[0.9970937,0.000486552,0.0003399766,0.0006712895,0.0005586225,0.0008498081],"domain_scores_gemma":[0.9978544,0.000050224,0.0001095638,0.001700264,0.0001398865,0.0001456278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001624057,0.00006686823,0.0005518478,0.000007109825,0.0003731768,0.00001800746,0.000304389,0.00006740118,0.9772847,0.0001803206,0.0001688568,0.01935328],"study_design_scores_gemma":[0.001879258,0.001740522,0.0007115214,0.00000880392,0.000008763881,0.000009986252,0.0001333686,0.00002405178,0.8160788,0.000281831,0.1788234,0.0002996459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858323,0.007237364,0.0002853605,0.004148546,0.0001398494,0.001766606,0.00003190283,0.00003785259,0.0005202594],"genre_scores_gemma":[0.9863849,0.0009937654,0.00005078499,0.002688891,0.0002398949,0.0003345867,0.0000789014,0.0001170975,0.009111197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1786545,"threshold_uncertainty_score":0.9437289,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039687494","doi":"10.1038/mt.2009.283","title":"Intelligent Design: Combination Therapy With Oncolytic Viruses","year":2009,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":209,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; McMaster University; University of Toronto","funders":"","keywords":"Oncolytic virus; Virotherapy; Radiation therapy; Medicine; Disease; Modalities; Clinical trial; Combination therapy; Cancer; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0919764287457091,"gpt":0.3806036980557098,"spread":0.2886272693100007,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006673618,0.0009432018,0.001236928,0.000300316,0.0001506289,0.0001436032,0.001001338,0.0006346073,0.00009657117],"category_scores_gemma":[0.00002500252,0.0007070504,0.0006256328,0.0005288728,0.0001725133,0.000006882456,0.0000685318,0.0004785829,0.0001215708],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001367317,"about_ca_system_score_gemma":0.0008701744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007707862,"about_ca_topic_score_gemma":0.000008658429,"domain_scores_codex":[0.9958983,0.001085759,0.0005997767,0.001069101,0.000656417,0.0006906528],"domain_scores_gemma":[0.9977444,0.00005411278,0.0003528473,0.001421149,0.000219549,0.0002079737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001797256,0.000474491,6.386497e-7,0.0001882203,0.0007974366,0.00006256596,0.00002288272,0.00004910045,0.0108749,0.00003003275,0.000308955,0.9853935],"study_design_scores_gemma":[0.001381612,0.01507155,6.325584e-7,0.0007087578,0.00007566623,0.00005316353,0.000004418825,0.000005933087,0.1078416,0.00009520258,0.873953,0.0008084127],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001193918,0.9876416,0.007807337,0.00004647436,0.00009109391,0.002888635,0.00001524804,0.00006163595,0.000254109],"genre_scores_gemma":[0.0002557954,0.9961931,0.0005732133,0.00118844,0.0001874922,0.0004901675,0.000342399,0.0002755974,0.0004938079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9845851,"threshold_uncertainty_score":0.9995381,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987468883","doi":"10.1038/mt.2013.220","title":"Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies","year":2013,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":199,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Immunogenic cell death; Virotherapy; Immune system; Programmed cell death; Cancer; Cancer cell; Cancer research; Immunotherapy; Antigen; Biology; Immunology; Medicine; Apoptosis","retraction":null,"screen_n_in":null,"score":{"opus":0.06464577896269096,"gpt":0.3904649689011866,"spread":0.3258191899384956,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002761949,0.0009052262,0.001108474,0.00007131164,0.0002979292,0.0002860205,0.0007503245,0.000499572,0.0002172907],"category_scores_gemma":[0.000005364267,0.0005758092,0.0008102888,0.0001445541,0.000152112,0.00001212375,0.00009346139,0.0002424315,0.000009087093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002783726,"about_ca_system_score_gemma":0.001304975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008864314,"about_ca_topic_score_gemma":0.0005537416,"domain_scores_codex":[0.9971753,0.0003622943,0.000517732,0.0009857519,0.0002026487,0.0007562733],"domain_scores_gemma":[0.9982328,0.00007033108,0.0003308959,0.001083506,0.0001382922,0.0001441531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000455473,0.00007881385,6.724636e-7,0.0003456334,0.001247058,0.000001917549,0.00005231327,0.00001289322,0.2350336,0.000009175743,0.00007297768,0.7626895],"study_design_scores_gemma":[0.001943568,0.003653463,8.079558e-7,0.000338754,0.0002856296,0.000008409057,0.00004073451,0.00004389442,0.07719069,0.00004970973,0.9157754,0.0006689271],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01118604,0.982399,0.0003698106,0.0001183269,0.0001660937,0.005413401,0.0002418589,0.00002562725,0.00007982603],"genre_scores_gemma":[0.0002760947,0.985205,0.0002456097,0.000390718,0.0004078616,0.01124751,0.0002638698,0.0002946456,0.001668693],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9157025,"threshold_uncertainty_score":0.9996693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003781492","doi":"10.1038/mt.2011.26","title":"Targeting Tumor Vasculature With an Oncolytic Virus","year":2011,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre; Robarts Clinical Trials; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Virus; Virology; Biology; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.02048468366080724,"gpt":0.275301676404647,"spread":0.2548169927438398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003334635,0.0002992679,0.0002041776,0.00007346898,0.0001246493,0.00004328423,0.0004793156,0.0001462343,0.0002302362],"category_scores_gemma":[0.00001581045,0.0002436061,0.0001242081,0.0001938947,0.000136004,0.00001012264,0.00005646607,0.0002142857,0.00004033566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002169974,"about_ca_system_score_gemma":0.0001500803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005649958,"about_ca_topic_score_gemma":0.00007714853,"domain_scores_codex":[0.9981399,0.0002277315,0.0001886488,0.0005983147,0.0003380285,0.0005073831],"domain_scores_gemma":[0.9987202,0.000004340919,0.00007596455,0.0008439708,0.0001520253,0.0002035187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004683611,0.0002429522,0.0003132987,0.000005477687,0.0001998766,0.0001172225,0.0001897577,0.0001027861,0.9892434,0.00003936269,0.00009472913,0.004767542],"study_design_scores_gemma":[0.00161994,0.008666907,0.0003938435,0.000008791741,0.00001225401,0.00003273827,0.00006173534,0.00008075677,0.9815633,0.0001524616,0.007007561,0.0003997056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932094,0.003055887,0.001962457,0.00003345815,0.00005175308,0.0004451407,0.000008342198,0.00004917871,0.001184394],"genre_scores_gemma":[0.994568,0.0002907027,0.002938224,0.001566338,0.0001545946,0.00008126135,0.0001008228,0.000122005,0.0001780251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008423955,"threshold_uncertainty_score":0.993397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112523289","doi":"10.1016/j.ymthe.2003.11.023","title":"Dystrophin Expression in Myofibers of Duchenne Muscular Dystrophy Patients Following Intramuscular Injections of Normal Myogenic Cells","year":2004,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":193,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôtel-Dieu de Québec; Hôpital de l'Enfant-Jésus; Université Laval; SNC-Lavalin (Canada)","funders":"","keywords":"Dystrophin; Duchenne muscular dystrophy; Muscular dystrophy; Exon; Biology; Immunosuppression; Molecular biology; Skeletal muscle; Medicine; Internal medicine; Endocrinology; Immunology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.003271101709141726,"gpt":0.2072330217986358,"spread":0.2039619200894941,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001238449,0.0002186631,0.0002878614,0.0001334298,0.00004821281,0.000005093566,0.0002449648,0.0002237618,0.0000136527],"category_scores_gemma":[0.00002591775,0.0002147284,0.0003646908,0.0002289472,0.0001140913,0.00001039968,0.00006700357,0.0001274383,0.000002200513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002094459,"about_ca_system_score_gemma":0.00007376277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009537169,"about_ca_topic_score_gemma":0.000008683853,"domain_scores_codex":[0.9986358,0.0001228307,0.0003913682,0.000369063,0.0001935891,0.0002873198],"domain_scores_gemma":[0.9992314,0.000006239329,0.0001567151,0.0004616929,0.00007864677,0.00006529556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000316146,0.0004591747,0.001498269,0.00002127114,0.0001267485,0.000006844183,0.0001453167,0.008968831,0.9877328,0.00004178224,0.000007575,0.0006752466],"study_design_scores_gemma":[0.003781619,0.0008049489,0.008592371,0.00003707729,0.00001747873,8.332895e-7,0.00007167472,0.000006864625,0.9859505,0.0003140216,0.0002144666,0.0002081124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948332,0.0009432033,0.003628308,0.0000214325,0.0001603887,0.0003235347,0.00001220258,0.000008398182,0.0000692802],"genre_scores_gemma":[0.9980934,0.0001917583,0.001428777,0.00009179502,0.00002168759,0.00003135898,0.0001034978,0.00003226477,0.00000552173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008961966,"threshold_uncertainty_score":0.8756369,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094495139","doi":"10.1038/sj.mt.6300039","title":"Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral Immunity","year":2006,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":193,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; McMaster University; Children's Hospital of Eastern Ontario; Discovery Centre; University of Ottawa","funders":"","keywords":"Oncolytic virus; Virology; Immunity; Virus; Biology; Immunology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.01166677736478592,"gpt":0.2766388029961481,"spread":0.2649720256313621,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035891,0.0002694113,0.0002528751,0.0001171118,0.0001050539,0.00002957761,0.0005089642,0.0002063349,0.00006393876],"category_scores_gemma":[0.000008117302,0.0002763451,0.0002321658,0.0002075087,0.0001768195,0.000007741663,0.00005695746,0.0001663537,0.00001214603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003587013,"about_ca_system_score_gemma":0.0002789683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004865089,"about_ca_topic_score_gemma":0.0001604027,"domain_scores_codex":[0.9980186,0.0004226637,0.0003096222,0.000429695,0.000393699,0.0004257544],"domain_scores_gemma":[0.99865,0.00001233618,0.0001252354,0.0009599815,0.0001730866,0.00007935253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002027632,0.0005986062,0.000612971,0.00001326584,0.00005876765,0.00002952125,0.00001822953,0.0009461778,0.9905264,0.000006176973,0.00007081222,0.005091472],"study_design_scores_gemma":[0.002438379,0.003581396,0.001108554,0.000008058141,0.00001139317,0.000002366327,0.00001604394,0.0002750332,0.9902379,0.0001223102,0.001904737,0.0002938413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995487,0.002415684,0.0008103347,0.00002579685,0.00006587796,0.0003757678,0.0000732734,0.00002249663,0.0007238166],"genre_scores_gemma":[0.9984904,0.000133871,0.0002494277,0.0004151316,0.00008854637,0.0000334248,0.0003464786,0.00007557598,0.000167124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00479763,"threshold_uncertainty_score":0.9999689,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020849247","doi":"10.1038/mt.2008.143","title":"The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma","year":2008,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jennerex Biotherapeutics (Canada)","funders":"","keywords":"Oncolytic virus; Hepatocellular carcinoma; Virology; Cancer research; Carcinoma; Medicine; Oncology; Biology; Internal medicine; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01138818154942036,"gpt":0.2318983847113721,"spread":0.2205102031619517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002885515,0.0003662665,0.0003203483,0.0001153802,0.0003837649,0.00007591813,0.0003639091,0.0001575313,0.00000999965],"category_scores_gemma":[0.00002136375,0.000267036,0.0001149055,0.0002849626,0.00055617,0.00001713561,0.00008708249,0.0002410165,0.000005271378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000327143,"about_ca_system_score_gemma":0.0002255646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007281334,"about_ca_topic_score_gemma":0.00005274688,"domain_scores_codex":[0.9977445,0.0003323514,0.0002679577,0.0005853202,0.0004528117,0.0006170615],"domain_scores_gemma":[0.9989511,0.00002716282,0.00009679519,0.0006828037,0.0001131595,0.0001289822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001971774,0.0002110717,0.4502653,0.000007489512,0.0001472424,0.0001222607,0.00007026675,0.00003549675,0.5452664,0.00001062287,0.00003612738,0.001855899],"study_design_scores_gemma":[0.004157107,0.002867654,0.1629829,0.00001563231,0.00001000016,0.00002577742,0.00006612465,0.000132906,0.8282561,0.0000260075,0.001035986,0.0004237727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892968,0.009562558,0.00009825111,0.0001053429,0.00004495898,0.0007784879,0.0000154325,0.00002118913,0.00007696318],"genre_scores_gemma":[0.9964079,0.002914779,0.0001083906,0.0002329828,0.00003873825,0.00006128115,0.00007159232,0.00007926815,0.00008505988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2872824,"threshold_uncertainty_score":0.9999782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1936207051","doi":"10.1038/mt.2015.156","title":"Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Blockade; Innate immune system; Acquired immune system; Immune system; Biology; Immunology; Cancer research; Medicine; Virology; Receptor; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02642568077100044,"gpt":0.271333762284272,"spread":0.2449080815132716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004087063,0.0002788484,0.0004364904,0.0001098931,0.000101755,0.00005997354,0.00008259719,0.00008852642,0.00001437239],"category_scores_gemma":[0.0000296625,0.0001995559,0.00006580458,0.0002519289,0.0003232327,0.0001463907,0.00001893572,0.0001727648,0.000002370759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005640042,"about_ca_system_score_gemma":0.0001453208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003368155,"about_ca_topic_score_gemma":0.000004143523,"domain_scores_codex":[0.9985667,0.0002125993,0.0002560987,0.0003628036,0.0003367074,0.0002650862],"domain_scores_gemma":[0.9991714,0.00006454402,0.0001442064,0.0002916978,0.0002171461,0.0001109545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0642684,0.0003762588,0.004086488,0.0000169979,0.0008579774,0.0003328724,0.002331808,0.000001015212,0.9120198,0.001023679,0.00007514389,0.01460956],"study_design_scores_gemma":[0.07703633,0.01200454,0.1046262,0.0002535928,0.0001067381,0.0007647625,0.0008613431,0.0001169724,0.783968,0.002315382,0.01718517,0.0007609738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624818,0.03260807,0.0005758798,0.002805518,0.0000620203,0.0009322196,0.00001025493,0.00007177182,0.0004524549],"genre_scores_gemma":[0.9898602,0.005715452,0.0006858834,0.003382252,0.00003304012,0.00006235477,0.00001282694,0.00005297095,0.0001949546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1280518,"threshold_uncertainty_score":0.8137651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969313893","doi":"10.1038/mt.2009.291","title":"Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy","year":2010,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"PerkinElmer Biosignal","funders":"National Cancer Institute; National Institutes of Health","keywords":"Small interfering RNA; Gene silencing; Doxorubicin; Liposome; Chemistry; RNA interference; Transfection; PEG ratio; Molecular biology; Genetic enhancement; Cationic liposome; Cancer research; RNA; Biochemistry; Biology; Gene; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01010478088680756,"gpt":0.258583486571748,"spread":0.2484787056849404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012288,0.0001764405,0.0002567988,0.00008837131,0.00009261904,0.00003787237,0.00005627529,0.00007755982,0.0003003308],"category_scores_gemma":[0.00001536934,0.0001210492,0.0001084859,0.0001775831,0.0001374296,0.0000575744,0.000007604272,0.00014133,0.000009607008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009719718,"about_ca_system_score_gemma":0.00003827073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003200266,"about_ca_topic_score_gemma":0.00001724922,"domain_scores_codex":[0.9990673,0.00002793534,0.0001590081,0.0002907329,0.0002055252,0.0002495126],"domain_scores_gemma":[0.9993434,0.00002789242,0.00005473379,0.000278284,0.0001465165,0.0001492053],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005808909,0.0001599577,0.002052422,0.000008746123,0.0001868852,0.00003656578,0.0001690541,0.000004285601,0.9771033,0.000263351,0.0001338746,0.01930068],"study_design_scores_gemma":[0.005525772,0.0005669462,0.007144349,0.00004826012,0.00004399562,0.00003108582,0.00005869186,0.0006511966,0.9780788,0.0002484942,0.00741494,0.000187398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943874,0.0007444358,0.00189451,0.002282234,0.00002095295,0.0004450936,0.00001042285,0.00006387183,0.0001510293],"genre_scores_gemma":[0.9916526,0.000281795,0.003011809,0.00461862,0.00007005236,0.00005645365,0.00002626955,0.00003920297,0.0002431961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01911328,"threshold_uncertainty_score":0.4936244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3146945747","doi":"10.1016/j.ymthe.2021.04.008","title":"Gene therapy for ALS: A review","year":2021,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institutes of Health; National Institute of Neurological Disorders and Stroke; Sächsische Aufbaubank; CHEO Research Institute","keywords":"Genetic enhancement; Biology; Gene; Computational biology; Genetics; Medicine; Virology","retraction":null,"screen_n_in":null,"score":{"opus":0.1662840641686352,"gpt":0.4545602627584998,"spread":0.2882761985898646,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000675928,0.0006710521,0.00361131,0.0001515746,0.00008009766,0.000055929,0.0004449605,0.0004385478,0.001207903],"category_scores_gemma":[0.0001303716,0.0004475531,0.002297285,0.0005372074,0.00007449662,0.00003250324,0.00007330213,0.0005583641,0.0001345979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000154141,"about_ca_system_score_gemma":0.0008336713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008591613,"about_ca_topic_score_gemma":1.44202e-7,"domain_scores_codex":[0.9964526,0.0005121679,0.0008106985,0.0008842269,0.0006938482,0.0006464486],"domain_scores_gemma":[0.9975933,0.0001324898,0.0002570395,0.00139665,0.0003461003,0.0002743778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003541787,0.0001680267,1.789879e-7,0.01818908,0.001105076,0.0002077388,0.000009081416,2.999493e-8,0.0004403352,0.00004182406,0.004969713,0.9748335],"study_design_scores_gemma":[0.001311216,0.0004653701,0.000001423038,0.05827969,0.0003809836,0.0001754528,4.92074e-7,8.545742e-7,0.00023653,0.00002700907,0.9387303,0.0003906892],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000009759164,0.990715,0.0003934107,0.001130243,0.0001236127,0.007230952,0.00004691643,0.00007627428,0.0002738924],"genre_scores_gemma":[6.602955e-7,0.9867415,0.001668271,0.006113307,0.0003202754,0.002626804,0.000910607,0.0002753268,0.001343178],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9744428,"threshold_uncertainty_score":0.9997976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141208964","doi":"10.1038/mt.2011.190","title":"Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells","year":2011,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Drug Research and Development; Encana (Canada); University of British Columbia","funders":"Canadian Institutes of Health Research; Alnylam Pharmaceuticals","keywords":"Gene silencing; Cationic polymerization; Nanoparticle; Chemistry; Antigen; Solid lipid nanoparticle; Composition (language); RNA interference; Gene; Cell biology; Biophysics; Biochemistry; Biology; Materials science; Nanotechnology; RNA; Immunology; Polymer chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02468615966362248,"gpt":0.2368702135300832,"spread":0.2121840538664607,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001050924,0.00008796755,0.000136108,0.0000712484,0.0000218026,0.00000300571,0.0001454903,0.00005953969,0.00000509317],"category_scores_gemma":[0.00001139441,0.00008230206,0.00006617969,0.0001081526,0.0000601575,0.000009270315,0.00003172291,0.000037115,0.000001539262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006296412,"about_ca_system_score_gemma":0.00003703317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001396078,"about_ca_topic_score_gemma":0.000008330853,"domain_scores_codex":[0.999248,0.00005922076,0.0003139154,0.0001527891,0.0001058371,0.0001202105],"domain_scores_gemma":[0.9994059,0.000004515795,0.0001650709,0.0002552106,0.0001498122,0.00001944469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001358169,0.0001716034,0.004728094,0.00002035518,0.00003136697,6.648339e-7,0.000666679,0.005333855,0.9885757,0.00005961995,0.000001345866,0.0002749277],"study_design_scores_gemma":[0.000333074,0.0003626867,0.01324788,0.00006709365,0.000003978225,9.162187e-7,0.00003706049,0.0002126073,0.9856049,0.00004520412,0.000005134721,0.00007950243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990261,0.0003474235,0.0003104008,0.000006728809,0.00002566197,0.0001656328,0.000004704245,0.000002966377,0.0001104494],"genre_scores_gemma":[0.9993315,0.0002613892,0.000315189,0.00004305693,0.00001326697,0.000009749152,0.000008780212,0.00001030386,0.000006738157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008519789,"threshold_uncertainty_score":0.3356181,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099538751","doi":"10.1038/mt.2013.111","title":"Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients","year":2013,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Transcription activator-like effector nuclease; Genome editing; Dystrophin; Biology; Duchenne muscular dystrophy; Genetics; CRISPR; Exon; Gene; Computational biology","retraction":null,"screen_n_in":null,"score":{"opus":0.002392924651279668,"gpt":0.2134090732554655,"spread":0.2110161486041858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007854398,0.0002571833,0.0001947244,0.00007794491,0.00006411053,0.00005468794,0.0001996319,0.0002230476,0.00006610035],"category_scores_gemma":[0.00003850014,0.0002568097,0.00009980881,0.0001168557,0.00002969164,0.00001147661,0.00006199425,0.0001834118,0.00002076716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003948576,"about_ca_system_score_gemma":0.00001255671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003410113,"about_ca_topic_score_gemma":0.000003852624,"domain_scores_codex":[0.998572,0.00009088366,0.0002857162,0.0004960779,0.0001997885,0.0003555435],"domain_scores_gemma":[0.999325,0.000008436235,0.00008927336,0.0003925888,0.00007943904,0.0001052544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003353888,0.00007740777,0.001288962,0.000004328203,0.00003007848,0.000004652218,0.00009286734,0.002099864,0.9934935,4.369837e-7,0.0009703512,0.001904025],"study_design_scores_gemma":[0.000986032,0.0001947625,0.01017924,0.00002860153,0.00000509517,7.324326e-7,0.0000525055,0.0005013665,0.9803419,0.00002943453,0.007395165,0.0002851994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9725012,0.001742179,0.02468622,0.00003017811,0.0005715109,0.0003733889,0.00002421143,0.0000288691,0.00004227766],"genre_scores_gemma":[0.9964368,0.000250039,0.002140835,0.0001375468,0.0002262385,0.00008228678,0.0005915012,0.00006328381,0.00007145182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02393565,"threshold_uncertainty_score":0.9999884,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2077697398","doi":"10.1006/mthe.2000.0077","title":"Transduction of Human CD34+CD38- Bone Marrow and Cord Blood-Derived SCID-Repopulating Cells with Third-Generation Lentiviral Vectors","year":2000,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Stem cell; Vesicular stomatitis virus; Bone marrow; Haematopoiesis; CD38; Transduction (biophysics); CD34; Viral vector; Cord blood; Virology; Genetic enhancement; Immunology; Molecular biology; Cell biology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.01829102356791838,"gpt":0.2711504399804154,"spread":0.252859416412497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002574445,0.000238693,0.0002286276,0.00007910892,0.0001677237,0.00004125213,0.0001332619,0.0001407812,0.0001291071],"category_scores_gemma":[0.000003644474,0.0002198403,0.00009996085,0.0001582774,0.0001781678,0.00001103006,0.00001526772,0.0001232865,0.000002705268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001082693,"about_ca_system_score_gemma":0.00004627899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008974013,"about_ca_topic_score_gemma":0.0001579966,"domain_scores_codex":[0.9984381,0.0002165695,0.0002787426,0.0004803577,0.0002931339,0.0002930932],"domain_scores_gemma":[0.9993194,0.000004146551,0.00009993897,0.0004124532,0.00008700086,0.00007701219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001569591,0.0001307174,0.0004453275,0.00001336289,0.0001618424,0.00001229055,0.0001138784,0.0003944408,0.9818833,0.000007407394,0.00002269203,0.0152451],"study_design_scores_gemma":[0.001918725,0.005265552,0.0004574704,0.00001499494,0.00002745449,0.00001891703,0.00002432385,0.00009779327,0.9916867,0.00003166433,0.0002073852,0.0002490048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971175,0.001819791,0.0003274125,0.0000732113,0.00003829671,0.0004076075,0.000008614754,0.00002154203,0.0001860646],"genre_scores_gemma":[0.998138,0.0005592213,0.0004911806,0.0001332006,0.0001181524,0.00003141982,0.0001293812,0.00005959657,0.0003398398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0149961,"threshold_uncertainty_score":0.8964826,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2036869628","doi":"10.1038/mt.2013.249","title":"Maraba Virus as a Potent Oncolytic Vaccine Vector","year":2013,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's Hospital of Eastern Ontario; McMaster University Medical Centre; Ottawa Hospital; University of Guelph; McMaster University","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Cancer Research Institute","keywords":"Oncolytic virus; Virology; Adjuvant; Antigen; Heterologous; Immunotherapy; Immune system; Immunity; Melanoma; Virus; Cancer immunotherapy; Vaccination; Biology; Virotherapy; Cancer vaccine; Immunology; Viral vector; Cancer research; Recombinant DNA; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01155414276625173,"gpt":0.2833689316756323,"spread":0.2718147889093806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002156749,0.0003123721,0.000234557,0.00009320111,0.000103875,0.00008612723,0.0004930642,0.0001970625,0.001094286],"category_scores_gemma":[0.00003751447,0.000280719,0.0002187623,0.0001989835,0.00005521642,0.000006846541,0.0001084949,0.0001836855,0.001200517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004564478,"about_ca_system_score_gemma":0.0001546744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001950316,"about_ca_topic_score_gemma":0.00004642476,"domain_scores_codex":[0.9980273,0.0001999232,0.0002577367,0.0005677091,0.0003765497,0.0005708029],"domain_scores_gemma":[0.9986156,0.00001132923,0.00007158255,0.0008939317,0.0001722978,0.00023525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00110252,0.0001810646,0.00009117638,0.000004945218,0.0001845857,0.000032792,0.00002819978,0.00004796007,0.9625468,0.00003159883,0.002147129,0.03360119],"study_design_scores_gemma":[0.001924051,0.004481327,0.001142839,0.000007754174,0.000007481375,0.00002966133,0.00001913337,0.00007122372,0.9628747,0.0003865684,0.02870441,0.0003508663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903713,0.005137286,0.0005127742,0.00136472,0.0001148091,0.0008763857,0.000007906126,0.00004358338,0.001571168],"genre_scores_gemma":[0.9916215,0.001326048,0.0002455838,0.004101065,0.0002160714,0.0002835782,0.00008317,0.0001039305,0.002019035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03325032,"threshold_uncertainty_score":0.9999645,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038304191","doi":"10.1038/mt.2010.98","title":"Potentiating Cancer Immunotherapy Using an Oncolytic Virus","year":2010,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Oncolytic virus; Immunotherapy; Cancer immunotherapy; Virology; Cancer; Virus; Virotherapy; Biology; Cancer research; Medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02575059554033427,"gpt":0.3444213482913968,"spread":0.3186707527510625,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000433445,0.0003037747,0.0002153141,0.0001002159,0.0001993524,0.0001003334,0.0005541555,0.0002571748,0.0002579151],"category_scores_gemma":[0.00001832772,0.0002970553,0.000182006,0.0002023314,0.0001328317,0.00001220271,0.00006281602,0.0003502089,0.00001248537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003140189,"about_ca_system_score_gemma":0.0002763872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003483568,"about_ca_topic_score_gemma":0.0005855914,"domain_scores_codex":[0.9980553,0.0001968739,0.000263314,0.0005822013,0.0003504776,0.0005518482],"domain_scores_gemma":[0.9985865,0.000007597551,0.0001114732,0.000961379,0.0001594875,0.0001735601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001000498,0.0001946872,0.0003307495,0.000003175187,0.0001551739,0.00001477346,0.00008666528,0.0005730987,0.9515347,0.00001654615,0.00002258816,0.04606735],"study_design_scores_gemma":[0.001505632,0.001404768,0.000296498,0.000006451673,0.000007712084,0.00001928917,0.0000228415,0.0009836573,0.9844227,0.0001172963,0.01082977,0.0003833883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933502,0.003277202,0.002324793,0.0001181767,0.0003194167,0.0004066876,0.00001549155,0.00006830579,0.0001197452],"genre_scores_gemma":[0.9946722,0.000946448,0.001788427,0.001703357,0.0004283494,0.00007494985,0.00004937693,0.0002016277,0.0001352675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04568396,"threshold_uncertainty_score":0.9999481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083627888","doi":"10.1016/j.ymthe.2005.06.002","title":"Prolonged Recovery of Retinal Structure/Function after Gene Therapy in an Rs1h-Deficient Mouse Model of X-Linked Juvenile Retinoschisis","year":2005,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Retinal Development and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Eye Institute","keywords":"Retinoschisis; Erg; Electroretinography; Biology; Retinal; Retinal degeneration; Retina; Genetic enhancement; Retinal Disorder; Molecular biology; Gene; Ophthalmology; Genetics; Medicine; Retinal detachment; Neuroscience","retraction":null,"screen_n_in":null,"score":{"opus":0.009429734580465837,"gpt":0.2267305361921917,"spread":0.2173008016117259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002176912,0.0002242134,0.000253785,0.0001218791,0.0000273434,0.00001255902,0.0002030189,0.0002064112,0.00004530352],"category_scores_gemma":[0.00001488267,0.0002064159,0.000139023,0.0001392677,0.00007862934,0.00001208542,0.00003367047,0.000106881,0.000001212728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001891259,"about_ca_system_score_gemma":0.00009866968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001389514,"about_ca_topic_score_gemma":0.00003107511,"domain_scores_codex":[0.9985499,0.0001228813,0.000426848,0.0004078946,0.0002460077,0.0002464687],"domain_scores_gemma":[0.9991938,0.000004211331,0.0001824118,0.0004360814,0.0001301467,0.00005336602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004146622,0.0002395896,0.00668933,0.000009491388,0.00004739992,0.000001169358,0.0002083395,0.006817651,0.971801,0.00001770039,0.00001924125,0.01000242],"study_design_scores_gemma":[0.001730268,0.00119231,0.006988371,0.00001025465,0.000007605954,0.00000143587,0.00002814225,0.0009980982,0.988134,0.000258788,0.0004103675,0.0002404101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941117,0.001898839,0.003337667,0.00008884043,0.000043444,0.0003801211,0.00002672295,0.00001007758,0.0001025461],"genre_scores_gemma":[0.9930367,0.0008972188,0.00532133,0.0003710766,0.00003256645,0.00004326819,0.0001549151,0.00003905592,0.0001038664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01633291,"threshold_uncertainty_score":0.8417397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979127187","doi":"10.1038/sj.mt.6300179","title":"Ras Transformation Mediates Reovirus Oncolysis by Enhancing Virus Uncoating, Particle Infectivity, and Apoptosis-dependent Release","year":2007,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":171,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Infectivity; Virus; Virology; Biology; Transformation (genetics); Apoptosis; Viral replication; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01009861249352629,"gpt":0.2865936530399548,"spread":0.2764950405464285,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001232442,0.000259062,0.0002165593,0.00008035947,0.000178549,0.00007018039,0.0001879079,0.0001929217,0.00004509406],"category_scores_gemma":[0.00007447814,0.000254628,0.0001140239,0.0002173052,0.0001012679,0.00001864048,0.00005340394,0.0001829926,0.00001903137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005413919,"about_ca_system_score_gemma":0.00007261142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000179918,"about_ca_topic_score_gemma":0.0006825944,"domain_scores_codex":[0.9980264,0.0002342589,0.0003530063,0.0004544494,0.0004143624,0.0005175362],"domain_scores_gemma":[0.9991222,0.00004569803,0.0001055932,0.0004076611,0.00009852471,0.0002203362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001306256,0.000169779,0.0005061624,0.00001066077,0.0001147733,0.000005853039,0.0002642673,0.00005674725,0.9378505,0.00001348727,0.00005956545,0.05964193],"study_design_scores_gemma":[0.001814864,0.002181579,0.0001691128,0.000008946266,0.0000161249,0.000006121925,0.00008872315,0.00007142937,0.993333,0.00009286229,0.001922641,0.0002945659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758953,0.004056496,0.01909961,0.0001787972,0.00005510093,0.0004430782,0.00001673062,0.00004056407,0.0002142841],"genre_scores_gemma":[0.996326,0.002358017,0.0001261378,0.0008401158,0.00007976939,0.00005579568,0.00008227592,0.00005585293,0.00007605294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05934736,"threshold_uncertainty_score":0.9999906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977890900","doi":"10.1038/mt.2012.146","title":"Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":171,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute","keywords":"Serotype; Virology; Strain (injury); Medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01446528722639093,"gpt":0.2636714118898322,"spread":0.2492061246634412,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003450993,0.0001703276,0.0003783303,0.0001536159,0.00005477532,0.000004080252,0.0001458465,0.0001057182,0.0001611832],"category_scores_gemma":[0.0000239304,0.0001383017,0.0000853184,0.0001759534,0.0001350253,0.0001121133,0.00001731593,0.0001499861,0.000007705618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002111844,"about_ca_system_score_gemma":0.00008754108,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005102259,"about_ca_topic_score_gemma":0.000003128312,"domain_scores_codex":[0.9986941,0.0003776057,0.0004360234,0.0001404423,0.00007268249,0.0002792065],"domain_scores_gemma":[0.9993185,0.0000514688,0.0002583357,0.0002938122,0.0000638385,0.00001408682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.152734,0.006354794,0.0005711626,0.00001305514,0.0004700547,0.000003410391,0.001546055,0.000004100484,0.7856073,0.0002261787,0.000002199774,0.05246766],"study_design_scores_gemma":[0.1094795,0.0204195,0.00848856,0.00003802829,0.0000400949,0.000007441382,0.00009986218,5.55475e-7,0.8604556,0.0000335414,0.0007652451,0.0001720659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954218,0.003325282,0.000315269,0.00001706824,0.0001545352,0.0006439513,0.00002974621,0.0000114445,0.00008096221],"genre_scores_gemma":[0.9994832,0.00007294374,0.0001682895,0.00004070086,0.000006258238,0.00002342107,0.0001054173,0.00002216169,0.00007757804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07484831,"threshold_uncertainty_score":0.563978,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3121721028","doi":"10.1016/j.ymthe.2021.01.018","title":"Circular RNAs: Expression, localization, and therapeutic potentials","year":2021,"lang":"en","type":"review","venue":"Molecular Therapy","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":170,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; China Scholarship Council","keywords":"Expression (computer science); Cell biology; Computational biology; Biology; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.02659851048504128,"gpt":0.3186886887014914,"spread":0.2920901782164501,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002266232,0.000679752,0.001144589,0.000124855,0.0001562866,0.0001465768,0.0004882911,0.0006382944,0.0001099221],"category_scores_gemma":[0.00009369116,0.0006115121,0.0007861123,0.0002701517,0.0001602767,0.000003736407,0.0002350716,0.000202435,0.0000181292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002936939,"about_ca_system_score_gemma":0.0003467343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003867201,"about_ca_topic_score_gemma":5.160961e-7,"domain_scores_codex":[0.9968794,0.0006866219,0.000577684,0.00109278,0.0003573908,0.0004061536],"domain_scores_gemma":[0.9979749,0.00002083764,0.0002982732,0.001329343,0.0001783756,0.0001982656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001324144,0.0001977385,0.00001576156,0.001946951,0.001277624,0.0001885716,0.00002318649,0.00002722515,0.02808726,0.0001623502,0.0009112755,0.9671488],"study_design_scores_gemma":[0.0004170851,0.00006589237,0.000002433188,0.001612877,0.0003493825,0.0001639959,0.00001224297,0.000002841322,0.01167284,0.000127178,0.9848936,0.0006796531],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001492385,0.9752054,0.02346107,0.00001584647,0.0002097622,0.0007812991,0.00004347768,0.00003780389,0.00009613936],"genre_scores_gemma":[0.0006137168,0.9964492,0.0001707812,0.000770229,0.0002339877,0.000205193,0.001181088,0.0002221707,0.0001535817],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9839823,"threshold_uncertainty_score":0.9996336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053328538","doi":"10.1038/mt.2012.188","title":"Myoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation","year":2012,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":168,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre hospitalier de l'Université Laval","funders":"Stem Cell Network","keywords":"Regenerative medicine; Myogenesis; Embryonic stem cell; Biology; Induced pluripotent stem cell; Duchenne muscular dystrophy; Cell biology; Stem cell; Muscular dystrophy; MyoD; Myocyte; Transplantation; Regeneration (biology); Cellular differentiation; Adult stem cell; Immunology; Genetics; Medicine; Gene; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01498351648349348,"gpt":0.2487507958059197,"spread":0.2337672793224262,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001817219,0.0002007913,0.0001427576,0.0000498643,0.0001326543,0.00004480228,0.0001400258,0.0001158132,0.00001034621],"category_scores_gemma":[0.00001054544,0.0001774657,0.0000783694,0.00009542616,0.00006454215,0.0000133341,0.00003461317,0.0001129017,0.000007717023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001566481,"about_ca_system_score_gemma":0.00003124509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005229954,"about_ca_topic_score_gemma":0.00001114432,"domain_scores_codex":[0.9986574,0.0001311215,0.0001498863,0.0003407717,0.0002785359,0.0004422896],"domain_scores_gemma":[0.9994676,0.00001957003,0.00005485959,0.0002640799,0.00003547981,0.0001584132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002655548,0.00006413095,0.004095311,0.00001347482,0.0001115847,0.00005184413,0.0003574443,0.0001571719,0.9912866,0.000004668552,0.000004363226,0.003587845],"study_design_scores_gemma":[0.002288586,0.0003356719,0.02724667,0.00003905864,0.00003324739,0.00002564632,0.0001037572,0.0001481282,0.9684305,0.00000661107,0.001033515,0.0003085645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850715,0.002285543,0.01201731,0.00005054452,0.00007306423,0.0002573204,0.00001596951,0.00002082341,0.000207944],"genre_scores_gemma":[0.9970176,0.0003169518,0.002097532,0.0001703615,0.00008327689,0.0000235069,0.0001936184,0.00004533548,0.00005182494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02315135,"threshold_uncertainty_score":0.7236841,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971532562","doi":"10.1038/mt.2014.21","title":"Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults","year":2014,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":162,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Oncolytics Biotech; University of Alabama at Birmingham","keywords":"Medicine; Clinical trial; Glioma; Oncology; Cancer research; Internal medicine; Pathology; Virology","retraction":null,"screen_n_in":null,"score":{"opus":0.05011960824218846,"gpt":0.3974668225247628,"spread":0.3473472142825744,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009182685,0.0001874577,0.0003443126,0.00007876755,0.0000371145,0.000008268707,0.0002974533,0.0001500726,0.0000115693],"category_scores_gemma":[0.00009697398,0.0001253076,0.0003362127,0.0001545026,0.0001633691,0.000002178547,0.0000278064,0.00007031093,0.000001272105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001843476,"about_ca_system_score_gemma":0.0001118081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003470807,"about_ca_topic_score_gemma":0.00009369972,"domain_scores_codex":[0.9981139,0.0004328957,0.0006060342,0.0003597096,0.0002219788,0.0002655051],"domain_scores_gemma":[0.9988316,0.00009713611,0.000204086,0.0006787875,0.0001235955,0.00006479117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2227908,0.002496673,0.00005800519,0.000009575544,0.00008697862,0.000002154383,0.00006967614,0.00001954757,0.5016098,0.00003737989,0.00003276317,0.2727866],"study_design_scores_gemma":[0.1001787,0.1121196,0.00006384912,0.00002402385,0.00001249464,0.000001036481,0.00001652386,0.0004102894,0.7761495,0.0001029835,0.01080396,0.0001169548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932163,0.003632849,0.001053482,0.0001618134,0.0002247986,0.001647392,0.00002972386,0.000004432483,0.00002917734],"genre_scores_gemma":[0.9933267,0.005806041,0.0002096583,0.00009713288,0.000204485,0.0002311433,0.00007190159,0.00003055848,0.00002242498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2745397,"threshold_uncertainty_score":0.5109895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988967544","doi":"10.1038/mt.2014.243","title":"Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients","year":2014,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Oncolytic virus; Medicine; Vaccinia; Pediatric cancer; Cancer; Virus; Immunology; Internal medicine; Cancer research; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01543497354646158,"gpt":0.3305967925986338,"spread":0.3151618190521723,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004460138,0.000288674,0.0003329028,0.0001909827,0.00006411672,0.00003651267,0.0003773143,0.000140306,0.00003990873],"category_scores_gemma":[0.00002002416,0.0002754319,0.00006727103,0.0003055412,0.00005794614,0.00001151283,0.00007162654,0.0001903862,0.000003028185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003263206,"about_ca_system_score_gemma":0.0001158926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002469156,"about_ca_topic_score_gemma":0.0006402637,"domain_scores_codex":[0.9977663,0.000546222,0.0003997091,0.0005615272,0.0003272425,0.0003990316],"domain_scores_gemma":[0.9989613,0.0000163411,0.0001428958,0.0006264854,0.0001290418,0.0001239877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005609088,0.004939811,0.03713812,0.00001818676,0.0001111206,0.000006390258,0.0005541196,0.0000673176,0.9095893,0.000004096136,0.00001412696,0.04194835],"study_design_scores_gemma":[0.03424226,0.08240093,0.06502092,0.00001633487,0.00005453904,0.000002601813,0.0001409192,0.0004572739,0.8161637,0.00009210873,0.0007032792,0.0007051529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957182,0.003229412,0.00003868472,0.00003562326,0.0000708579,0.00084938,0.00001418741,0.00001239267,0.00003122452],"genre_scores_gemma":[0.9975302,0.001699349,0.00002853962,0.0003644433,0.0001033312,0.000130977,0.00004634034,0.00007285393,0.0000240149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09342559,"threshold_uncertainty_score":0.9999698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2323633757","doi":"10.1006/mthe.2002.0608","title":"Baculoviral IAP Repeat-Containing-4 Protects Optic Nerve Axons in a Rat Glaucoma Model","year":2002,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Retinal Development and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Aegera Therapeutics (Canada); Children's Hospital of Eastern Ontario","funders":"National Eye Institute","keywords":"Optic nerve; Glaucoma; Intravitreal administration; Genetic enhancement; Retinal ganglion cell; Axon; Neuroprotection; Retinal; Biology; Retina; Intraocular pressure; Trabecular meshwork; Cell biology; Medicine; Ophthalmology; Pharmacology; Neuroscience; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01536229252081232,"gpt":0.2312035298238709,"spread":0.2158412373030585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000151625,0.0002581814,0.0001960658,0.00008896282,0.00006617978,0.0000445427,0.0002575587,0.0001751177,0.00004719643],"category_scores_gemma":[0.000037268,0.000247406,0.0001448861,0.0001737226,0.00006112378,0.000007291923,0.00006467685,0.0001407524,0.00003217636],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002198636,"about_ca_system_score_gemma":0.00004571987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002017949,"about_ca_topic_score_gemma":0.00001658577,"domain_scores_codex":[0.9985896,0.00009202869,0.000254581,0.0004740474,0.0001833111,0.0004064151],"domain_scores_gemma":[0.9993938,0.000004568124,0.00006684279,0.0004046605,0.00004324134,0.00008691174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004298738,0.0002361432,0.003839506,0.00001468118,0.0000812791,0.0002350646,0.0003846892,0.0007853655,0.986486,0.0003380425,0.000744356,0.006425036],"study_design_scores_gemma":[0.009756065,0.00233957,0.002932829,0.00009356032,0.00002409774,0.000138721,0.0002610719,0.03648643,0.9276223,0.002021596,0.01638914,0.00193457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884364,0.003026609,0.003094536,0.0003809187,0.00005392252,0.0005250878,0.000001758783,0.00002628489,0.004454473],"genre_scores_gemma":[0.9950547,0.0002887181,0.002366606,0.0006373876,0.00003072411,0.0001495383,0.00004756977,0.00004582162,0.001378905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05886361,"threshold_uncertainty_score":0.9999978,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978558644","doi":"10.1038/mt.2011.132","title":"A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma","year":2011,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Melanoma; Biology; Virus; Viral replication; Immunology; Cancer research; Virology; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05540121754432453,"gpt":0.326185745949199,"spread":0.2707845284048745,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071052,0.0004505149,0.0006469524,0.000180188,0.00006623072,0.00002383353,0.0005480854,0.000210453,0.0001244082],"category_scores_gemma":[0.0001184855,0.0003428046,0.0001874357,0.0003952571,0.0002663103,0.000009935646,0.00007892724,0.0003069082,0.000009007716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004529557,"about_ca_system_score_gemma":0.0004732497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007003802,"about_ca_topic_score_gemma":0.0002122087,"domain_scores_codex":[0.996527,0.0007415771,0.0007266868,0.0008303335,0.0005647262,0.0006096702],"domain_scores_gemma":[0.9982393,0.0000419195,0.0003273344,0.0009035664,0.0002771499,0.0002107391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.7367545,0.01149132,0.004712,0.00008165264,0.002326692,0.0003801986,0.000759519,0.0002254313,0.2065457,0.0002588238,0.00003065639,0.03643356],"study_design_scores_gemma":[0.1170363,0.09645776,0.00155891,0.00006624806,0.0001024494,0.000006458016,0.0000611822,0.0002739729,0.783324,0.0002711051,0.0001435149,0.0006980644],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711851,0.000597076,0.0251999,0.00001409796,0.00009876327,0.002766916,0.00004717666,0.000021021,0.00006993466],"genre_scores_gemma":[0.9912184,0.00002841029,0.007776773,0.000269796,0.00004201853,0.0002981925,0.0001582944,0.0001257557,0.00008238103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6197181,"threshold_uncertainty_score":0.9999024,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033344463","doi":"10.1038/mt.2010.103","title":"Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus","year":2010,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Vector-Borne Animal Diseases","field":"Agricultural and Biological Sciences","cited_by":157,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Toronto; Ottawa Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Virology; Identification (biology); Biology; Virus; Genetically modified organism; Computational biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01655870000313833,"gpt":0.258277134714643,"spread":0.2417184347115046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000140841,0.0001254259,0.0001361655,0.00001361543,0.00007006501,0.000056749,0.0003444929,0.00009868523,0.0005459242],"category_scores_gemma":[0.00004327429,0.00005595579,0.0001095492,0.0001899773,0.00008433146,0.00008157264,0.0000246601,0.00009743786,0.00008999936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007404306,"about_ca_system_score_gemma":0.00001674152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002998665,"about_ca_topic_score_gemma":0.000214757,"domain_scores_codex":[0.9989592,0.00008233435,0.0002368899,0.0002841459,0.0002551905,0.0001822472],"domain_scores_gemma":[0.999496,0.00003463683,0.00009803537,0.0001458373,0.0000968343,0.0001286356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009229439,0.0002420335,0.00027759,0.000001398438,0.00001389951,0.000007546506,0.00001972252,0.000005348254,0.9363571,0.001952108,0.00001287053,0.06101806],"study_design_scores_gemma":[0.0001751447,0.000511982,0.2477594,0.00000214856,0.00001062582,0.000003700608,0.00001716941,0.0002198067,0.7468856,0.002715857,0.001541753,0.0001568264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986078,0.0002174148,0.00003587601,0.0002701782,0.00007230182,0.0002387082,0.00002840365,0.00005284026,0.0004764352],"genre_scores_gemma":[0.9991688,0.00007869984,0.00007068926,0.0004852608,0.00007624999,0.00002323317,0.0000310637,0.000002464641,0.00006352824],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2474818,"threshold_uncertainty_score":0.5977488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135002443","doi":"10.1038/mt.2014.194","title":"First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity","year":2014,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Oncolytic virus; Vaccinia; Virus; Virology; Virulence; Viral replication; Medicine; Biology; Cancer research; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01722536157705793,"gpt":0.3013002170472189,"spread":0.284074855470161,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009063981,0.0002818112,0.0004195492,0.0001386665,0.00007842912,0.00003648778,0.0004265385,0.0002005179,0.00001892801],"category_scores_gemma":[0.00004991488,0.0002698046,0.000087673,0.0001847618,0.00007444849,0.000008924677,0.0001537283,0.0002332214,0.000007142194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003688275,"about_ca_system_score_gemma":0.00007129575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003374002,"about_ca_topic_score_gemma":0.003295848,"domain_scores_codex":[0.9976445,0.000651266,0.0003585077,0.0006080089,0.0003451568,0.000392551],"domain_scores_gemma":[0.9987153,0.00004620556,0.000142452,0.0008987826,0.00008197903,0.0001152886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004542791,0.0006656527,0.01470977,0.00005645864,0.0001458071,0.00002973396,0.000277238,0.0003739561,0.9738542,0.000006914172,0.00001232924,0.00532516],"study_design_scores_gemma":[0.008865285,0.01803074,0.05253065,0.0001117061,0.00002237891,0.00002936873,0.0002489132,0.0004919011,0.9179742,0.00005050947,0.001114049,0.0005303557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969665,0.001312292,0.0003167713,0.0001799309,0.00003951865,0.001059201,0.00002574297,0.0000149379,0.00008511081],"genre_scores_gemma":[0.9986448,0.0009131563,0.00002829714,0.0001498018,0.00005519249,0.00006334519,0.00001720608,0.00006140564,0.00006679732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05588004,"threshold_uncertainty_score":0.9999754,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}